(Q48943114)

English

Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.

scientific article published on 22 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. (English)

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

David P Skoner

1

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Eli O Meltzer

2

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Henry Milgrom

3

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Paul Stryszak

4

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Ariel Teper

5

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Heribert Staudinger

6

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

language of work or name

0 references

publication date

22 August 2011

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Journal of Asthma

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

48

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

8

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

848-859

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

The treatment of asthma in children: inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Long-term effects of budesonide or nedocromil in children with asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy,

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Once-daily evening administration of mometasone furoate in asthma treatment initiation

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Drug delivery performance of the mometasone furoate dry powder inhaler

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Evaluating the effects of asthma therapy on childhood growth: principles of study design

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2011.604883

21 January 2018

Identifiers

10.3109/02770903.2011.604883

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

1 reference

Europe PubMed Central

17 February 2018

http://europepmc.org/abstract/MED/21854342

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48943114&oldid=1510072067"